Non-Small Cell Lung Cancer (Molecular Pathology Tests Current
Metastatic non-small cell lung cancer (NSCLC) therapy, in the last two decades, by focusing on the molecular profile of tumor cells to a large extent driven by histology and treatment strategies has changed. A mutation in lung cancer cells, amplification, insertion, deletion and includes many chromosomal abnormalities such as translocation.
